ADAP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Adaptimmune Therapeutics (ADAP) Earnings Date & Reports

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ADAP is expected to report earnings to rise 144.92% to -12 cents per share on May 15

Adaptimmune Therapeutics ADAP Stock Earnings Reports

Q1'25

Est.

$-0.12

Q4'24

Missed

by $0.02

Q3'24

Est.

$-0.01

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.12

The last earnings report on March 20 showed earnings per share of -4 cents, missing the estimate of -2 cents. With 851.24K shares outstanding, the current market capitalization sits at 78.46M.

View a ticker or compare two or three

Compare

ADAP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ADAP
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of vaccines and cancer immunotherapy products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

60 Jubilee Avenue

Phone

+44 1235430000

Employees

449

Web

https://www.adaptimmune.com